 - To test for association of polymorphisms in Fc-gamma Fcγ receptors IIa HR131 and IIIa VF158 with progression-free survival and clinical response in patients with follicular non-Hodgkin lymphoma treated with rituximab and CHOP chemotherapy comprising cyclophosphamide, doxorubicin hydrochloride, vincristine, and prednisone. 